title: Regulatory divergence.
authors.affiliation: Medicines and Healthcare products Regulatory Agency, London, UK. Alasdair.breckenridge@mhra.gsi.gov.uk
authors.forename: Alasdair
authors.initials: A
authors.lastname: Breckenridge
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control; D005260:Female; D005464:Fluorobenzenes / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium